Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cavalli

Showing results (291-300 of 350) with videos related to

Pageof 35
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1996
The last 3 months of life of cancer patients: medical aspects and role of home-care services in southern SwitzerlandC Sessa, E Roggero, S Pampallona, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1987
A phase II study of carboplatin in advanced or metastatic stomach cancerM Beer, F Cavalli, S B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)J Bernhard, M Castiglione-Gertsch, S F Schmitz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncologyV Tamassia, A Battaglia, F Ganzina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancerM Rozencweig, W ten Bokkel Huinink, F Cavalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive daysI Wolff, K Bench, J H Beijnen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
Childhood acute promyelocytic leukemia in NicaraguaA Malta Corea, C Pacheco Espinoza, A Cantù Rajnoldi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetics of VP16-213 given by different administration methodsM D'Incalci, P Farina, C Sessa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?J Bernhard, B Thürlimann, S F Schmitz, et al.
British Journal of Haematology|May 19, 2004
ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysisG Martinelli, E Cocorocchio, F Peccatori, et al.
Pageof 35

Showing results (291-300 of 350) with videos related to

Sort By:
Pageof 35
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1996
The last 3 months of life of cancer patients: medical aspects and role of home-care services in southern SwitzerlandC Sessa, E Roggero, S Pampallona, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1987
A phase II study of carboplatin in advanced or metastatic stomach cancerM Beer, F Cavalli, S B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)J Bernhard, M Castiglione-Gertsch, S F Schmitz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncologyV Tamassia, A Battaglia, F Ganzina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancerM Rozencweig, W ten Bokkel Huinink, F Cavalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive daysI Wolff, K Bench, J H Beijnen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
Childhood acute promyelocytic leukemia in NicaraguaA Malta Corea, C Pacheco Espinoza, A Cantù Rajnoldi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetics of VP16-213 given by different administration methodsM D'Incalci, P Farina, C Sessa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?J Bernhard, B Thürlimann, S F Schmitz, et al.
British Journal of Haematology|May 19, 2004
ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysisG Martinelli, E Cocorocchio, F Peccatori, et al.
Pageof 35